These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 16959169

  • 1. Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation.
    Kaltenthaler E, Brazier J, De Nigris E, Tumur I, Ferriter M, Beverley C, Parry G, Rooney G, Sutcliffe P.
    Health Technol Assess; 2006 Sep; 10(33):iii, xi-xiv, 1-168. PubMed ID: 16959169
    [Abstract] [Full Text] [Related]

  • 2. A randomised controlled trial of computerised cognitive behaviour therapy for the treatment of depression in primary care: the Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) trial.
    Littlewood E, Duarte A, Hewitt C, Knowles S, Palmer S, Walker S, Andersen P, Araya R, Barkham M, Bower P, Brabyn S, Brierley G, Cooper C, Gask L, Kessler D, Lester H, Lovell K, Muhammad U, Parry G, Richards DA, Richardson R, Tallon D, Tharmanathan P, White D, Gilbody S, REEACT Team.
    Health Technol Assess; 2015 Dec; 19(101):viii, xxi-171. PubMed ID: 26685904
    [Abstract] [Full Text] [Related]

  • 3. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
    Health Quality Ontario .
    Ont Health Technol Assess Ser; 2019 Dec; 19(6):1-199. PubMed ID: 30873251
    [Abstract] [Full Text] [Related]

  • 4. The second Randomised Evaluation of the Effectiveness, cost-effectiveness and Acceptability of Computerised Therapy (REEACT-2) trial: does the provision of telephone support enhance the effectiveness of computer-delivered cognitive behaviour therapy? A randomised controlled trial.
    Brabyn S, Araya R, Barkham M, Bower P, Cooper C, Duarte A, Kessler D, Knowles S, Lovell K, Littlewood E, Mattock R, Palmer S, Pervin J, Richards D, Tallon D, White D, Walker S, Worthy G, Gilbody S.
    Health Technol Assess; 2016 Nov; 20(89):1-64. PubMed ID: 27922448
    [Abstract] [Full Text] [Related]

  • 5. Clinical effectiveness, cost-effectiveness and acceptability of low-intensity interventions in the management of obsessive-compulsive disorder: the Obsessive-Compulsive Treatment Efficacy randomised controlled Trial (OCTET).
    Lovell K, Bower P, Gellatly J, Byford S, Bee P, McMillan D, Arundel C, Gilbody S, Gega L, Hardy G, Reynolds S, Barkham M, Mottram P, Lidbetter N, Pedley R, Molle J, Peckham E, Knopp-Hoffer J, Price O, Connell J, Heslin M, Foley C, Plummer F, Roberts C.
    Health Technol Assess; 2017 Jun; 21(37):1-132. PubMed ID: 28681717
    [Abstract] [Full Text] [Related]

  • 6. Group cognitive behavioural therapy for postnatal depression: a systematic review of clinical effectiveness, cost-effectiveness and value of information analyses.
    Stevenson MD, Scope A, Sutcliffe PA, Booth A, Slade P, Parry G, Saxon D, Kalthenthaler E, group cognitive behavioural therapy for postnatal depression advisory group.
    Health Technol Assess; 2010 Sep; 14(44):1-107, iii-iv. PubMed ID: 20863477
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of computerized cognitive-behavioural therapy for the treatment of depression in primary care: findings from the Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) trial.
    Duarte A, Walker S, Littlewood E, Brabyn S, Hewitt C, Gilbody S, Palmer S.
    Psychol Med; 2017 Jul; 47(10):1825-1835. PubMed ID: 28228182
    [Abstract] [Full Text] [Related]

  • 8. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [Abstract] [Full Text] [Related]

  • 9. Low-intensity cognitive-behaviour therapy interventions for obsessive-compulsive disorder compared to waiting list for therapist-led cognitive-behaviour therapy: 3-arm randomised controlled trial of clinical effectiveness.
    Lovell K, Bower P, Gellatly J, Byford S, Bee P, McMillan D, Arundel C, Gilbody S, Gega L, Hardy G, Reynolds S, Barkham M, Mottram P, Lidbetter N, Pedley R, Molle J, Peckham E, Knopp-Hoffer J, Price O, Connell J, Heslin M, Foley C, Plummer F, Roberts C.
    PLoS Med; 2017 Jun; 14(6):e1002337. PubMed ID: 28654682
    [Abstract] [Full Text] [Related]

  • 10. The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.
    Loveman E, Green C, Kirby J, Takeda A, Picot J, Payne E, Clegg A.
    Health Technol Assess; 2006 Jan; 10(1):iii-iv, ix-xi, 1-160. PubMed ID: 16409879
    [Abstract] [Full Text] [Related]

  • 11. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J, Jones J, Takeda A, Davidson P, Price A.
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [Abstract] [Full Text] [Related]

  • 12. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
    Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS.
    Health Technol Assess; 2008 Apr; 12(11):1-278, iii. PubMed ID: 18405470
    [Abstract] [Full Text] [Related]

  • 13. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM, Hockenhull J, Bagust A, Boland A, Dickson R, Todd D.
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [Abstract] [Full Text] [Related]

  • 14. Computerised cognitive behaviour therapy for obsessive-compulsive disorder: a systematic review.
    Tumur I, Kaltenthaler E, Ferriter M, Beverley C, Parry G.
    Psychother Psychosom; 2007 Jun; 76(4):196-202. PubMed ID: 17570957
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Digital IAPT: the effectiveness & cost-effectiveness of internet-delivered interventions for depression and anxiety disorders in the Improving Access to Psychological Therapies programme: study protocol for a randomised control trial.
    Richards D, Duffy D, Blackburn B, Earley C, Enrique A, Palacios J, Franklin M, Clarke G, Sollesse S, Connell S, Timulak L.
    BMC Psychiatry; 2018 Mar 02; 18(1):59. PubMed ID: 29499675
    [Abstract] [Full Text] [Related]

  • 17. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.
    Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.
    Health Technol Assess; 2006 Aug 02; 10(27):iii-iv, ix-xi, 1-164. PubMed ID: 16904046
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.
    Olthuis JV, Watt MC, Bailey K, Hayden JA, Stewart SH.
    Cochrane Database Syst Rev; 2015 Mar 05; (3):CD011565. PubMed ID: 25742186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.